Filing
Spy
Filing
Spy
Home
About
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2020 Q4
13 of 14 quarters
Total Value
$34.36M
Total Shares
338.2K
Net Share Change
-325.7K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$34.36M
338.2K
0.1%
TRIM
-325.7K
(-49.1%)
Viking Global Investors
$34.36M
338.2K shares
TRIM
-325.7K
(-49.1%)
KRTX — Karuna Therapeutics Inc - FilingSpy